Study the effect of parijatak ghana vati in low back pain

A randomized controlled clinical study to evaluate the efficacy of parijatak ghan vati And nirgundi ghan vati in the management of gridhrasi w.s.r. to sciatica

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/054487

Enrollment

144

Registered

2023-06-27

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: G998- Other specified disorders of nervous system in diseases classified elsewhere

Interventions

Intervention1: Parijatak Ghana Vati: Parijatak Ghana Vati 1500 mg twice daily with lukewarm water before meals for 60 days Control Intervention1: Nirgundi Ghana Vati: Nirgundi Ghana Vati 1500 mg twice

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed patient of Sciatica using Digital X-Ray(lumber spine) Diagnosed patient having signs of Gridhrasi Patient willing to participate in the trial.

Exclusion criteria

Exclusion criteria: Patients with other systemic disorders like Diabetes, CA spine Patients with history of any direct or indirect trauma to spine. Patient having congenital deformities of spine. Pregnant females and Lactating mothers. Immunocompromised patients. Patient requiring emergency surgical intervention.

Design outcomes

Primary

Measure	Time frame
Reduction in painTimepoint: 60 days	—

Secondary

Measure	Time frame
To compare analgesic effect of parijatak ghan and nirgundi ghanTimepoint: 60 days	—

Countries

India

Contacts

Public ContactDr Eknath Kulkarni

Ayurved Seva Sangh Ayurved Mahavidyalaya Nashik

ekulkarni6@gmail.com9850071240

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026